OTC Pharmaceuticals - Southeast Asia

The OTC Pharmaceuticals market in Southeast Asia is projected to generate a revenue of US$9.26bn in 2024.
This market is expected to experience an annual growth rate of 6.98% (CAGR 2024-2029).
Among the various submarkets, the largest one is Vitamins & Minerals, which is estimated to have a market volume of US$2.30bn in 2024.
When compared globally, the United States stands out as the market leader, generating a revenue of US$41.24bn in 2024.
In terms of per capita revenue, in Southeast Asia is expected to generate US$13.37 per person in 2024.
Furthermore, online sales are projected to contribute 16.42% of the total revenue in the OTC Pharmaceuticals market by 2024.
The OTC pharmaceutical market in Southeast Asia is experiencing a growing demand for traditional herbal remedies.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Southeast Asia is experiencing significant growth and development due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in the region are shifting towards self-medication and over-the-counter (OTC) pharmaceutical products. This can be attributed to the increasing awareness and accessibility of healthcare information through digital platforms, which has empowered consumers to take more control over their own health. Additionally, the rising cost of healthcare services and the convenience of OTC products have also contributed to the growing demand for self-medication options.Trends in the market reflect the changing dynamics of the healthcare industry in Southeast Asia. One prominent trend is the increasing availability and variety of OTC pharmaceutical products in pharmacies and retail outlets. This is driven by the expanding product portfolios of pharmaceutical companies, as well as the growing number of partnerships and collaborations between manufacturers and retailers. Furthermore, there is a growing emphasis on preventive healthcare and wellness, leading to the introduction of OTC products targeting specific health conditions such as vitamins, supplements, and herbal remedies.Local special circumstances play a role in shaping the OTC Pharmaceuticals market in Southeast Asia. For instance, the region's diverse cultural and traditional practices influence the demand for certain types of OTC products. Traditional remedies and herbal medicines have a strong presence in Southeast Asian countries, and consumers often prefer these products due to their perceived natural and holistic benefits. Additionally, the regulatory landscape varies across countries, with some nations having stricter regulations on the sale and distribution of pharmaceutical products, which can impact market dynamics.Underlying macroeconomic factors also contribute to the development of the OTC Pharmaceuticals market in Southeast Asia. The region's economic growth and rising disposable incomes have led to an increase in healthcare spending, including the purchase of OTC products. The expanding middle class and urbanization have also contributed to the growth of modern retail channels, where OTC pharmaceutical products are widely available. Furthermore, the aging population in Southeast Asia has created a demand for OTC products that cater to age-related health conditions.In conclusion, the OTC Pharmaceuticals market in Southeast Asia is experiencing growth and development due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the availability of a wide range of OTC products, cultural influences, and economic growth are all contributing to the expansion of this market in the region. As consumer empowerment and healthcare awareness continue to increase, the OTC Pharmaceuticals market in Southeast Asia is expected to thrive in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.